Glenmark recalls 6,528 bottles of BP drug in US

Glenmark Pharmaceuticals is recalling 6,528 bottles of Diltiazem Hydrochloride extended-release capsules, a medication used to treat high blood pressure in the American market due to failed dissolution specifications, informed USFDA in its latest Enforcement Report.

The affected lot has been produced in India and is being recalled for “failed dissolution specifications”, the USFDA said.

“Out of Specification (OOS) was reported in a test of dissolution at the 12th month time point in long-term stability study,” it noted.

Glenmark initiated Class II recall of the drug across the US on March 26 this year.

As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Related Posts

  • Pharma
  • June 13, 2025
  • 18 views
Two die, one critical after a gas leak at Pharma City

Anakapalli:  In a tragic accident that took place at Jawaharlal Nehru Pharmacy, Parawada in Anakapalli, two died and one is said to be in critical condition following a gas leak…

  • Pharma
  • June 13, 2025
  • 78 views
DCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seized

Officials found New Al-Shifa Medical and General Stores located at Zamistanpur in Musheerabad was running without a proper drug licence. Hyderabad: A medical shop in Hyderabad was raided by officials…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Two die, one critical after a gas leak at Pharma City

Two die, one critical after a gas leak at Pharma City

DCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seized

DCA raids medical shop in Hyderabad, illegal medicines worth Rs 25K seized

Pharma firm Captab Biotech banned in Punjab for 3 years following adverse drug reactions

Pharma firm Captab Biotech banned in Punjab for 3 years following adverse drug reactions

FUJIFILM resolves to detect Breast Cancer early with Apollo Hospitals

FUJIFILM resolves to detect Breast Cancer early with Apollo Hospitals